Research Archive — Page 31 of 134
-
April 9, 2024
Heart disease, depression linked by inflammation: study
Coronary artery disease and major depression may be genetically linked via inflammatory pathways to an increased risk for cardiomyopathy, a degenerative heart muscle disease, researchers at Vanderbilt University Medical Center and Massachusetts General Hospital have found. -
April 5, 2024
Eunyoung Choi’s gastric cancer research merits AACR-Debbie’s Dream funding
Ongoing research by Eunyoung Choi, PhD, into how cells transform into abnormal versions of themselves that are the precursors to stomach cancer has received support from the American Association for Cancer Research. -
April 4, 2024
Tick bites and alpha-gal syndrome focus of $3.5M research grant
Vanderbilt's Scott Smith, MD, PhD, has been awarded a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to study the human immune response to tick bites and its role in preventing tick-borne illnesses. -
April 3, 2024
Excess salt linked to heart disease deaths in low-income group: study
Excessive consumption of dietary sodium likely was responsible for up to 30% of cardiovascular disease-related deaths among mostly low-income participants in a large cohort study conducted by Vanderbilt University Medical Center. -
April 2, 2024
VUMC research staff honored for excellence in the lab, clinic
Laboratory and administrative personnel at Vanderbilt University Medical Center were honored on March 29 for research excellence during the 20th annual Research Staff Awards Ceremony. -
April 1, 2024
Cell-specific variations in gene regulation may be key to treating pulmonary fibrosis
An international research team co-led by Vanderbilt University Medical Center has revealed how variations in gene regulation in different cell types drive pulmonary fibrosis, a progressive respiratory disorder characterized by scarring and loss of functional lung tissue. -
March 28, 2024
VUMC team discovers antibodies that may prevent severe respiratory illness
Using a technique developed at Vanderbilt University Medical Center, researchers identified antibodies that are excellent leads as potential therapies for human parainfluenza virus 3, a leading cause of acute and potentially fatal respiratory illness.